Endonovo Therapeutics Overview
- Year Founded
-
2008
- Status
-
Public
- Stock Symbol
-
ENDV
- Investments
-
6
Endonovo Therapeutics General Information
Description
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.
Contact Information
Website
www.endonovo.comCorporate Office
- 6320 Canoga Avenue
- 15th Floor, Woodland Hills
- Los Angeles, CA 91367
- United States
Corporate Office
- 6320 Canoga Avenue
- 15th Floor, Woodland Hills
- Los Angeles, CA 91367
- United States
Endonovo Therapeutics Stock Performance
As of 09-Nov-2026, Endonovo Therapeutics’s current market cap is $181K with 1.81B shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $181K | 1.81B | 711K |
Endonovo Therapeutics Financials Summary
As of 30-Jun-2025, Endonovo Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 7,045 | 7,175 | 9,830 | 10,715 |
| Revenue | 0 | 10 | 140 | 135 |
| EBITDA | (925) | (941) | 8,854 | (16,506) |
| Net Income | (2,458) | (2,797) | 6,925 | (18,475) |
| Total Assets | 18 | 18 | 638 | 1,281 |
| Total Debt | 6,896 | 6,870 | 7,073 | 7,153 |
Endonovo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Endonovo Therapeutics Comparisons
Industry
Financing
Details
Endonovo Therapeutics Competitors (1)
One of Endonovo Therapeutics’s competitors is Achaogen, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Achaogen | Formerly VC-backed | South San Francisco, CA |
Endonovo Therapeutics Patents
Endonovo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018156919-A1 | Devices and methods for the delivery of non-thermal therapeutic and prophylactic pulsed electromagnetic fields from a mobile communications device | Inactive | 24-Feb-2017 | ||
| EP-3272854-A1 | Biological molecules produced by electromagnetically stimulating living mammalian cells | Inactive | 21-Jul-2016 | ||
| JP-2018007647-A | Biological molecules produced by electromagnetically stimulating living mammalian cells | Pending | 15-Jul-2016 | ||
| US-20170186346-A1 | Adaptable tensioned-fabric framing system | Inactive | 29-Dec-2015 | ||
| US-20190351249-A1 | Method and apparatus for electromagnetic treatment of living systems | Inactive | 04-Nov-2014 | A61N2/008 |
Endonovo Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Endonovo Therapeutics Investments & Acquisitions (6)
Endonovo Therapeutics’s most recent deal was a Merger/Acquisition with Western Star Concrete. The deal was made on 01-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Western Star Concrete | 01-Mar-2023 | Merger/Acquisition | Construction and Engineering | ||
| Rio Grande Neurosciences | 27-Dec-2017 | Merger/Acquisition | Therapeutic Devices | ||
| Rio Grande Neurosciences (Pulsed Electromagnetic Field Therapy Assets) | 22-Dec-2017 | Corporate Asset Purchase | Buildings and Property | ||
| WeHealAnimals | 16-Nov-2013 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| The Aviva Companies | 09-Apr-2013 | Merger/Acquisition | Other Commercial Services |
Endonovo Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Endonovo Therapeutics FAQs
-
When was Endonovo Therapeutics founded?
Endonovo Therapeutics was founded in 2008.
-
Where is Endonovo Therapeutics headquartered?
Endonovo Therapeutics is headquartered in Los Angeles, CA.
-
What industry is Endonovo Therapeutics in?
Endonovo Therapeutics’s primary industry is Biotechnology.
-
Is Endonovo Therapeutics a private or public company?
Endonovo Therapeutics is a Public company.
-
What is Endonovo Therapeutics’s stock symbol?
The ticker symbol for Endonovo Therapeutics is ENDV.
-
What is the current market cap of Endonovo Therapeutics?
The current market capitalization of Endonovo Therapeutics is $181K.
-
Who are Endonovo Therapeutics’s competitors?
Achaogen is a competitor of Endonovo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process